{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:36:49Z","timestamp":1770230209755,"version":"3.49.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To investigate independent risk and protective factors associated with adverse reactions following rabies vaccination in a Chinese population; to develop and validate a predictive nomogram for clinical utility; to support risk stratification management in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on data from 806 patients who visited the Animal Bite Outpatient Clinic of Ningbo Ninth Hospital between September 2023 and August 2025. Variables were screened using LASSO regression, and a multivariate logistic regression-based nomogram model was constructed. The model\u2019s performance was evaluated using receiver operating characteristic (ROC) curves, calibration curves, decision curve analysis, and ten-fold cross-validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This study identified high-risk exposure grade (OR\u202f=\u202f1.37), bilateral deltoid vaccination (OR\u202f=\u202f4.93), history of allergy (OR\u202f=\u202f5.07), and delayed wound management (OR\u202f=\u202f2.13) as significant risk factors (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). In contrast, a 4-dose immunization schedule (OR\u202f&amp;lt;\u202f0.01) and greater injection-site skinfold thickness (OR\u202f&amp;lt;\u202f0.01) were key protective factors. The constructed nomogram demonstrated excellent discriminative ability, with AUC values of 0.826 in the training set and 0.817 in the test set. Ten-fold cross-validation yielded an accuracy of 80.0%. Decision curve analysis indicated a clinical net benefit threshold ranging from 4 to 97%. Subgroup analysis newly revealed that hypertensive patients experienced a 4.4-fold increase in risk (OR\u202f=\u202f4.43) following high-risk exposure. Additionally, vaccination during summer and autumn was associated with significantly elevated risks (OR range: 2.11\u20133.74).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study is the first to identify bilateral deltoid vaccination as an independent risk factor for adverse reactions to rabies vaccine. The constructed nomogram model demonstrates high accuracy in identifying high-risk individuals. Clinically, it is recommended that high-risk exposure patients receive single-site vaccination combined with a 4-dose regimen, with wound management completed within 24\u202fh. Enhanced monitoring is advised for hypertensive patients to mitigate potential risks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1721524","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:47:25Z","timestamp":1770187645000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for adverse events following rabies vaccination: a multivariate analysis of real-world data"],"prefix":"10.3389","volume":"14","author":[{"given":"Hao","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Emergency, Ningbo Ninth Hospital","place":["Ningbo, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, Ningbo Ninth Hospital","place":["Ningbo, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiye","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Emergency, Ningbo Ninth Hospital","place":["Ningbo, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"101204","DOI":"10.1016\/j.coviro.2022.101204","article-title":"Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy","volume":"53","author":"de Melo","year":"2022","journal-title":"Curr Opin Virol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/vaccines11081377","article-title":"Efficiency comparative approach of plant-produced monoclonal antibodies against rabies virus infection","volume":"11","author":"Lumlertdacha","year":"2023","journal-title":"Vaccines"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"102316","DOI":"10.1016\/j.tmaid.2022.102316","article-title":"Predictors of possible exposure to rabies in travellers: a case-control study","volume":"47","author":"Bantjes","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"102697","DOI":"10.1016\/j.tmaid.2024.102697","article-title":"Real-world evidence of rabies post-exposure prophylaxis in Serbia: nation-wide observational study (2017-2019)","volume":"58","author":"Banovi\u0107","year":"2024","journal-title":"Travel Med Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e2205461","DOI":"10.1002\/advs.202205461","article-title":"Treat the \"untreatable\" by a photothermal agent: triggering heat and immunological responses for rabies virus inactivation","volume":"10","author":"Bai","year":"2023","journal-title":"Adv Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12916-023-02821-x","article-title":"Strategies to interrupt rabies transmission for the elimination goal by 2030 in China (STRATEGIC): a modelling study","volume":"21","author":"Chen","year":"2023","journal-title":"BMC Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.3201\/eid2612.200303","article-title":"Animal rabies surveillance, China, 2004-2018","volume":"26","author":"Feng","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3390\/vaccines10081229","article-title":"COVID-19 vaccination in China: adverse effects and its impact on health care working decisions on booster dose","volume":"10","author":"Luo","year":"2022","journal-title":"Vaccines"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"102735","DOI":"10.1016\/j.tmaid.2024.102735","article-title":"Immunogenicity of 4-dose Essen intramuscular regimen for rabies post-exposure prophylaxis: a multi-center cross-sectional study in China","volume":"60","author":"Hou","year":"2024","journal-title":"Travel Med Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s00259-025-07453-2","article-title":"Predicting PD-L1 expression status in NSCLC using radiomic analysis of 18F-FDG-PET\/CT images","volume":"53","author":"Kiss","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1630061","DOI":"10.3389\/fimmu.2025.1630061","article-title":"Development and validation of a nomogram for predicting overall survival in patients with primary central nervous system germ cell tumors","volume":"16","author":"Yao","year":"2025","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.amjmed.2024.10.007","article-title":"Characteristics of vaccine safety observational studies and authors' attitudes: a systematic review","volume":"138","author":"Barosa","year":"2025","journal-title":"Am J Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/vaccines12050555","article-title":"Importance of examining incidentality in vaccine safety assessment","volume":"12","author":"Suzumura","year":"2024","journal-title":"Vaccines"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/14760584.2023.2262571","article-title":"Harmonizing the collection of solicited adverse events in prophylactic vaccine clinical trials","volume":"22","author":"Cheuvart","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.15585\/mmwr.mm7249a2","article-title":"Progress in immunization safety monitoring - worldwide, 2020-2022","volume":"72","author":"Blau","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1473-3099(20)30985-3","article-title":"Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study","volume":"21","author":"Marks","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"540.e1","DOI":"10.1016\/j.cmi.2022.11.009","article-title":"Effect of same-arm versus cross-arm administration of sequential doses of BNT162b2 on short-term vaccine effectiveness-a retrospective cohort study","volume":"29","author":"Grupel","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.anai.2023.06.015","article-title":"Understanding food allergy through neuroimmune interactions in the gastrointestinal tract","volume":"131","author":"Burns","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1016\/j.jaip.2022.08.045","article-title":"The combined use of chronological and morphological criteria in the evaluation of immediate penicillin reactions: evidence from a large study","volume":"10","author":"Romano","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.bioactmat.2024.05.008","article-title":"Accelerated infected wound healing by probiotic-based living microneedles with long-acting antibacterial effect","volume":"38","author":"Jin","year":"2024","journal-title":"Bioact Mater"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"101315","DOI":"10.1016\/j.mtbio.2024.101315","article-title":"Multifunctional hydrogel based on polyvinyl alcohol\/chitosan\/metal polyphenols for facilitating acute and infected wound healing","volume":"29","author":"Zhou","year":"2024","journal-title":"Mater Today Bio"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1080\/14760584.2021.1915777","article-title":"Immunogenicity and safety of a high-dose and prolonged-schedule hepatitis B vaccine among chronic kidney disease patients: a randomized, parallel-controlled trial","volume":"20","author":"Feng","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jconrel.2021.06.038","article-title":"Impact of injection sites on clinical pharmacokinetics of subcutaneously administered peptides and proteins","volume":"336","author":"Zou","year":"2021","journal-title":"J Control Release"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.7326\/M21-3023","article-title":"Risk for shoulder conditions after vaccination: a population-based study using real-world data","volume":"175","author":"Zheng","year":"2022","journal-title":"Ann Intern Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"00565","DOI":"10.1016\/S1473-3099(25)00565-1","article-title":"Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-Centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial","author":"Anywaine","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s43856-025-00851-5","article-title":"Rabies virus large protein-derived T-cell immunogen facilitates rapid viral clearance and enhances protection against lethal challenge in mice","volume":"5","author":"Bai","year":"2025","journal-title":"Commun Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3390\/vaccines10081178","article-title":"DNA-vaccine-induced immune response correlates with lower viral SARS-CoV-2 titers in a ferret model","volume":"10","author":"Compagnone","year":"2022","journal-title":"Vaccines"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1080\/22221751.2022.2078226","article-title":"Recombinant adeno-associated virus serotype 9 AAV-RABVG expressing a rabies virus G protein confers long-lasting immune responses in mice and non-human primates","volume":"11","author":"Shi","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"102316","DOI":"10.1016\/j.tmaid.2022.102316","article-title":"Predictors of possible exposure to rabies in travellers: a case-control study","volume":"47","author":"Bantjes","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e189300","DOI":"10.1172\/JCI189300","article-title":"Integrative mapping of preexisting influenza immune landscapes predicts vaccine response","volume":"135","author":"Hao","year":"2025","journal-title":"J Clin Invest"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e2131034","DOI":"10.1001\/jamanetworkopen.2021.31034","article-title":"Association of self-reported high-risk allergy history with allergy symptoms after COVID-19 vaccination","volume":"4","author":"Li","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/vaccines11020437","article-title":"Self-reported allergic adverse events following inactivated SARS-CoV-2 vaccine (TURKOVAC\u2122) among general and high-risk population","volume":"11","author":"Kara","year":"2023","journal-title":"Vaccines"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e2125524","DOI":"10.1001\/jamanetworkopen.2021.25524","article-title":"Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system","volume":"4","author":"Warren","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"984016","DOI":"10.3389\/fimmu.2022.984016","article-title":"IL-17 and IL-22 are pivotal cytokines to delay wound healing of S. Aureus and P. aeruginosa infected skin","volume":"13","author":"Lecron","year":"2022","journal-title":"Front Immunol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41419-021-04294-3","article-title":"The emerging roles of neutrophil extracellular traps in wound healing","volume":"12","author":"Zhu","year":"2021","journal-title":"Cell Death Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"29380","DOI":"10.1021\/acsami.1c07656","article-title":"Dopamine-substituted multidomain peptide hydrogel with inherent antimicrobial activity and antioxidant capability for infected wound healing","volume":"13","author":"Hussain","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/vaccines13030215","article-title":"Antibody persistence of human diploid cell rabies vaccine administrated using the four-versus five-dose Essen intramuscular regimen in post-exposure prophylaxis: a prospective cohort study among the Chinese population","volume":"13","author":"Wu","year":"2025","journal-title":"Vaccines"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"111692","DOI":"10.1016\/j.mad.2022.111692","article-title":"Social environment improves the cytokine profile and lymphoproliferative response in chronologically old and prematurely aging mice","volume":"206","author":"Garrido","year":"2022","journal-title":"Mech Ageing Dev"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3390\/vaccines10081177","article-title":"Protectivity of COVID-19 vaccines and its relationship with humoral immune response and vaccination strategy: a one-year cohort study","volume":"10","author":"Tanir","year":"2022","journal-title":"Vaccines"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3390\/vaccines12111209","article-title":"Immunogenicity persistence of different immunization regimens of rabies vaccine in the 10-60 years age group: a follow-up report based on phase III clinical trial","volume":"12","author":"Wang","year":"2024","journal-title":"Vaccines"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2022.03.019","article-title":"Breast cancer survivors' typhoid vaccine responses: chemotherapy, obesity, and fitness make a difference","volume":"103","author":"Kiecolt-Glaser","year":"2022","journal-title":"Brain Behav Immun"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"100928","DOI":"10.1016\/j.eclinm.2021.100928","article-title":"Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine","volume":"36","author":"Pellini","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1655819","DOI":"10.3389\/fimmu.2025.1655819","article-title":"Personalized immunization to optimize vaccine immunogenicity: exploring the multidimensional effects of host intrinsic factors, external intervention strategies, and the external environment","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/10408444.2024.2445021","article-title":"Nomograms applicability in clinical toxicology - enhancing precision in clinical decision-making: a systematic review","volume":"55","author":"Sharif","year":"2025","journal-title":"Crit Rev Toxicol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e2124502","DOI":"10.1001\/jamanetworkopen.2021.24502","article-title":"Trends in human papillomavirus vaccine safety concerns and adverse event reporting in the United States","volume":"4","author":"Sonawane","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1119124","DOI":"10.3389\/fimmu.2022.1119124","article-title":"A nomogram based on HBeAg, AST, and age to predict non-minimal liver inflammation in CHB patients with ALT <80 U\/L","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1435838","DOI":"10.3389\/fimmu.2024.1435838","article-title":"A preliminary probabilistic nomogram model for predicting renal arteriolar damage in IgA nephropathy from clinical parameters","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"104743","DOI":"10.1016\/j.ebiom.2023.104743","article-title":"Differences in SARS-CoV-2 specific humoral and cellular immune responses after contralateral and ipsilateral COVID-19 vaccination","volume":"95","author":"Ziegler","year":"2023","journal-title":"EBioMedicine"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"113665","DOI":"10.1016\/j.celrep.2023.113665","article-title":"Ipsilateral immunization after a prior SARS-CoV-2 mRNA vaccination elicits superior B cell responses compared to contralateral immunization","volume":"43","author":"Jiang","year":"2024","journal-title":"Cell Rep"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"745541","DOI":"10.3389\/fimmu.2021.745541","article-title":"Immune response to hepatitis B virus vaccine among people living with HIV: a meta-analysis","volume":"12","author":"Tian","year":"2021","journal-title":"Front Immunol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e505","DOI":"10.1002\/mco2.505","article-title":"A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancer","volume":"5","author":"Huo","year":"2024","journal-title":"MedComm (2020)"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1550206","DOI":"10.3389\/fimmu.2025.1550206","article-title":"The clinical significance of T-cell regulation in hypertension treatment","volume":"16","author":"Fu","year":"2025","journal-title":"Front Immunol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1161\/HYPERTENSIONAHA.121.17955","article-title":"Immune system and microvascular remodeling in humans","volume":"79","author":"Rizzoni","year":"2022","journal-title":"Hypertension"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"107879","DOI":"10.1016\/j.phrs.2025.107879","article-title":"IL-17 as a therapeutic target in cardiovascular diseases: mechanistic insights and translational opportunities","volume":"219","author":"Ma","year":"2025","journal-title":"Pharmacol Res"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.cjca.2024.08.270","article-title":"Advances in understanding of the role of immune cell phenotypes in hypertension and associated vascular disease","volume":"40","author":"Berillo","year":"2024","journal-title":"Can J Cardiol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1161\/ATVBAHA.124.321689","article-title":"Role of immune cells in perivascular adipose tissue in vascular injury in hypertension","volume":"45","author":"Berillo","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/vaccines9040363","article-title":"Vaccine quality is a key factor to determine thermal stability of commercial Newcastle disease (ND)vaccines","volume":"9","author":"Osman","year":"2021","journal-title":"Vaccines"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jcis.2021.03.106","article-title":"Sepiolite-zeolite powder doped with capric acid phase change microcapsules for temperature-humidity control","volume":"595","author":"Wang","year":"2021","journal-title":"J Colloid Interface Sci"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/glia.24129","article-title":"Early-life thermal stress mediates long-term alterations in hypothalamic microglia","volume":"70","author":"Ben-Nun","year":"2022","journal-title":"Glia"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/cells10061392","article-title":"Current insights into immunology and novel therapeutics of atopic dermatitis","volume":"10","author":"Kader","year":"2021","journal-title":"Cells"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1080\/14760584.2022.2144239","article-title":"Genetic predisposition to adverse events in Chinese children aged 3-24 months after diphtheria, tetanus, acellular pertussis and haemophilus influenzae type b combined vaccination","volume":"21","author":"Ma","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/vaccines11010193","article-title":"S trimer derived from SARS-CoV-2 B.1.351 and B.1.618 induced effective immune response against multiple SARS-CoV-2 variants","volume":"11","author":"Wang","year":"2023","journal-title":"Vaccines"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"875236","DOI":"10.3389\/fimmu.2022.875236","article-title":"Successive site translocating inoculation improved T cell responses elicited by a DNA vaccine encoding SARS-CoV-2 S protein","volume":"13","author":"Tian","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1721524\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:47:26Z","timestamp":1770187646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1721524\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":63,"alternative-id":["10.3389\/fpubh.2026.1721524"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1721524","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"article-number":"1721524"}}